Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease
Yuji Matsuzawa
Correspondence Sumitomo Hospital, 5-3-20 Nakanoshima, Kita-KU, Osaka 530-0005, Japan
Email matsuzawa-yuji@sumitomo-hp.or.jp
The relationship between cardiovascular disease and the metabolic syndrome is now well known but is not yet fully elucidated. In this review, Yuji Matsuzawa discusses the role of intra-abdominal visceral fat accumulation and the release of bioactive substances termed adipocytokines in the development of disorders contributing to the metabolic syndrome.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic stateInternational Journal of Obesity Original Article
Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic stateInternational Journal of Obesity Original Article
Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic stateInternational Journal of Obesity Original Article
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesityNature Medicine Article (01 Aug 2001)
See all 56 matches for Research